Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brookings Institution
Payers
Pharma industry rips 'draconian' price negotiation provision
Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs said the new trend is damaging and will stunt innovation.
Noah Tong
Aug 30, 2023 12:01am
Brookings: A look at profitability in Medicare Advantage
Jul 13, 2022 3:55pm
Brookings: Zero-dollar premiums could boost ACA coverage
Jun 29, 2022 3:08pm
Microsoft forms AI coalition with big names in healthcare
Jan 18, 2022 1:00pm
MA and Part D plans face COVID-19 uncertainty for 2021 bids
May 29, 2020 1:19pm
Charges for common surprise billing culprits increased: analysis
Dec 6, 2019 3:29pm